Program Description
The goal of this program is to offer healthcare professionals the opportunity to review the latest clinical data and approaches in the management of osteoporosis and Paget’s disease of bone.

Target Audience
The program is intended for clinical practitioners and clinical investigators involved in the management of metabolic bone disease.

Educational Objectives
At the conclusion of this program, participants should be able to

• Highlight the current management and treatment of osteoporosis and discuss ways to improve therapeutic outcomes for patients
• Explore ways to enhance the treatment of Paget’s disease of bone
• Identify how novel attributes of bisphosphonates can improve the management and treatment of metabolic bone disease

Disclaimer
© 2006 Medical Education Resources, Inc. All rights reserved. None of the contents may be reproduced in any form without prior written permission from Scinexa.

The views and opinions expressed in this activity are those of the faculty. They do not reflect the views of Novartis Pharmaceuticals Corporation, any other manufacturer of pharmaceuticals, Medical Education Resources, Inc., or Scinexa, LLC.

The recommendations made in this program are based upon a combination of randomized clinical trials, current guidelines, and the clinical practice experience of the participating panelists. Any medications, diagnostic procedures or treatments discussed by the panelists should not be utilized without evaluation of their patient's conditions. Participants are urged to consult the full prescribing information on any drug mentioned in this activity for recommended dosage, indications, contraindications, warnings, precautions, and adverse effects before prescribing any medication.